Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 06606 NH HEALTH-B > Detailed Quotes

06606 NH HEALTH-B

14.520
-0.080-0.55%
Closed 09/30 16:08 CCT
High
14.640
Open
14.600
Turnover
10.95M
Low
14.060
Pre Close
14.600
Volume
761.00K
Market Cap
6.24B
P/E(TTM)
Loss
52wk High
36.350
Shares
429.91M
P/E(Static)
Loss
52wk Low
13.260
Float Cap
6.24B
Bid/Ask %
-10.15%
Historical High
89.650
Shs Float
429.91M
Volume Ratio
0.56
Historical Low
13.260
Dividend TTM
--
Div Yield TTM
--
P/B
2.57
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.18%
Amplitude
3.97%
Avg Price
14.388
Lot Size
500
Float Cap
6.24B
Bid/Ask %
-10.15%
Historical High
89.650
Shs Float
429.91M
Volume Ratio
0.56
Historical Low
13.260
Dividend TTM
--
P/B
2.57
Dividend LFY
--
Turnover Ratio
0.18%
Amplitude
3.97%
Avg Price
14.388
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
New Horizon Health Ltd is a Chinese investment holding company mainly engaged in the R & D, clinical development, test operation and commercialization of colorectal cancer, gastric cancer and cervical cancer screening products. The company sells Chang Weiqing, Pupu and other products to customers through its own network, contract sales organization (CSO) and online or electronic platforms operated by medical clinics. The company's pylorus (a fecal-based self-test for gastric cancer screening test) and Gongzenqing (a non-invasive urine cervical cancer home screening test) are under development.
CEO: Yeqing Zhu
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...